Patents by Inventor Jeremy Foster

Jeremy Foster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ?-lactamase targeted photosensitizer for pesticide and pest detection
    Patent number: 10874107
    Abstract: Photoactivatable pesticide compounds and methods for the use thereof in the elimination and detection of pests are provided.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: December 29, 2020
    Assignees: The General Hospital Corporation, New England Biolabs
    Inventors: Tayyaba Hasan, Ulysses W. Sallum, Barton Slatko, Jeremy Foster
  • BETA-LACTAMASE TARGETED PHOTOSENSITIZER FOR PESTICIDE AND PEST DETECTION
    Publication number: 20200154710
    Abstract: Photoactivatable pesticide compounds and methods for the use thereof in the elimination and detection of pests are provided.
    Type: Application
    Filed: June 20, 2018
    Publication date: May 21, 2020
    Inventors: Tayyaba Hasan, Ulysses W. Sallum, Barton Slatko, Jeremy Foster
  • BETA-LACTAMASE TARGETED PHOTOSENSITIZER FOR PESTICIDE AND PEST DETECTION
    Publication number: 20160073634
    Abstract: Photoactivatable pesticide compounds and methods for the use thereof in the elimination and detection of pests are provided.
    Type: Application
    Filed: June 21, 2013
    Publication date: March 17, 2016
    Inventors: Tayyaba Hasan, Ulysses W. Sallum, Barton Slatko, Jeremy Foster
  • Identification and use of cofactor independent phosphoglycerate mutase as a drug target for pathogenic organisms and treatment of the same
    Publication number: 20060111848
    Abstract: Present embodiments of the invention describe computational methods for performing a systematic, genome-wide search for novel drug targets in pathogenic organisms for example, the human filarial parasites. Cofactor independent phosphoglycerate mutase (iPGM) was identified by this search as a candidate target for identifying therapeutic agents for use in treating animal or plant subjects infected with parasitic nematodes, microbial pathogens including microsporidia, fungi etc. A consensus amino acid or nucleotide sequence that characterizes iPGM is further provided.
    Type: Application
    Filed: December 22, 2005
    Publication date: May 25, 2006
    Applicant: New England Biolabs, Inc.
    Inventors: Clotilde Carlow, Yinhua Zhang, Jeremy Foster, Sanjay Kumar